Traws Pharma, Inc. 8-K

What Happened
Traws Pharma, Inc. (TRAW) filed a Current Report on Form 8‑K dated May 15, 2026 to report results of operations and financial condition and to furnish an earnings press release. The filing includes a Regulation FD disclosure of the earnings release and attaches the press release as Exhibit 99.1 (Press Release, dated May 15, 2026). The cover page interactive XBRL data is included as Exhibit 104.

Key Details

• Filing date: May 15, 2026 (Form 8‑K).
• Reported items: Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).
• Exhibit included: 99.1 — Press Release dated May 15, 2026 (earnings/financial results disclosure).
• Exhibit 104: Cover Page Interactive Data File (inline XBRL).

Why It Matters
This 8‑K publicly distributes Traws Pharma’s earnings/financial results and complies with Regulation FD, meaning material financial information was shared broadly to all investors at the same time. Earnings press releases can move the stock and affect investor decisions because they summarize revenue, profitability and operational results (and sometimes guidance). Investors should read the attached May 15, 2026 press release and related SEC filings (e.g., upcoming 10‑Q or 10‑K) for the specific revenue, net income, cash flow figures and any management commentary.